Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of Sabin strain inactivated poliovirus vaccine in healthy 2-month-old infants
ChiCTR1900023690Phase 3Completed
- Sponsor
- Henan Provincial Center for Disease Control and Prevention
- Start
- Sep 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis (2 arms), sponsored by Henan Provincial Center for Disease Control and Prevention. Primary endpoints: Seroconversion rates to polioviruses, Antibody levels to polioviruses and 3 more. Started Sep 2016; status: completed.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ChiCTR1900023690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023690.